These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3265840)
1. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Fuxe K; Sundström E; Agnati LF; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):589-91. PubMed ID: 3265840 [No Abstract] [Full Text] [Related]
2. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839 [No Abstract] [Full Text] [Related]
3. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment. Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376 [TBL] [Abstract][Full Text] [Related]
4. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827 [TBL] [Abstract][Full Text] [Related]
5. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. Quik M; Parameswaran N; McCallum SE; Bordia T; Bao S; McCormack A; Kim A; Tyndale RF; Langston JW; Di Monte DA J Neurochem; 2006 Sep; 98(6):1866-75. PubMed ID: 16882311 [TBL] [Abstract][Full Text] [Related]
6. N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey. Jacobowitz DM; Burns RS; Chiueh CC; Kopin IJ Psychopharmacol Bull; 1984; 20(3):416-22. PubMed ID: 6332329 [No Abstract] [Full Text] [Related]
7. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse. Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525 [TBL] [Abstract][Full Text] [Related]
8. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058 [TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient. Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136 [TBL] [Abstract][Full Text] [Related]
10. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related]
11. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum. Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001 [TBL] [Abstract][Full Text] [Related]
12. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
13. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets. Perry TL; Jones K; Hansen S; Wall RA Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859 [TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse. Weihmuller FB; Bruno JP; Neff NH; Hadjiconstantinou M Eur J Pharmacol; 1990 May; 180(2-3):369-72. PubMed ID: 2365010 [TBL] [Abstract][Full Text] [Related]
15. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues. Fries DS; de Vries J; Hazelhoff B; Horn AS J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197 [TBL] [Abstract][Full Text] [Related]
17. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Yong VW; Perry TL; Krisman AA Neurosci Lett; 1986 Jan; 63(1):56-60. PubMed ID: 3485266 [TBL] [Abstract][Full Text] [Related]
18. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135 [TBL] [Abstract][Full Text] [Related]